Illumina gene sequencing analysis
As a global leader in gene sequencing platforms, Illumina has achieved over 80% market share in NGS through patents and consumables, with sequencing costs reduced to $200.
0Uses7Likes9Views
What this skill does
As a global leader in gene sequencing platforms, Illumina has achieved over 80% market share in NGS through patents and consumables, with sequencing costs reduced to $200.
- Clarifies goals, inputs, and success criteria
- Preserves evidence and marks uncertain boundaries
- Produces structured, editable results